Treating psychiatric disorders in children and adolescents with psychotropic medication does not increase the risk of developing substance use, misuse, or substance use disorder and, in fact, appears to reduce the risk in individuals with pediatric attention-deficit/hyperactivity disorder (ADHD), major depressive disorder, and psychotic disorders. Researchers published their findings in the Journal of Child and Adolescent Psychopharmacology.